Old Web
English
Sign In
Acemap
>
authorDetail
>
S. S. Taflan
S. S. Taflan
Istanbul University
Medicine
Physical therapy
Internal medicine
Infliximab
Discontinuation
4
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
POS0814 DRUG RETENTION RATE, REASONS FOR DISCONTINUATION AND OUTCOME OF INFLIXIMAB USE IN BEHÇET SYNDROME
2021
Annals of the Rheumatic Diseases
Sinem Nihal Esatoglu
B. Tukek
S. S. Taflan
Yilmaz Ozyazgan
Didar Ucar
Vedat Hamuryudan
Yesim Ozguler
Emire Seyahi
Melike Melikoglu
Ugur Uygunoglu
Aksel Siva
Zekayi Kutlubay
Izzet Fresko
Sabahattin Yurdakul
Halil Yazici
Gulen Hatemi
Show All
Source
Cite
Save
Citations (0)
AB0364 DO PATIENTS PARTICIPATING IN MEETINGS REPRESENT THE ACTUAL PATIENT POPULATION IN BEHÇET SYNDROME
2021
Annals of the Rheumatic Diseases
S. S. Taflan
Sinem Nihal Esatoglu
Yesim Ozguler
B. Yurttas
Melike Melikoglu
Gulen Hatemi
Show All
Source
Cite
Save
Citations (0)
SAT0258 DRUG RETENTION RATE AND PROGNOSIS AFTER DISCONTINUATION OF INFLIXIMAB IN PATIENTS WITH BEHÇET SYNDROME
2020
Annals of the Rheumatic Diseases
Sinem Nihal Esatoglu
B. Tukek
S. S. Taflan
Yilmaz Ozyazgan
Didar Ucar
Emire Seyahi
Melike Melikoglu
Vedat Hamuryudan
Ugur Uygunoglu
Aksel Siva
Izzet Fresko
S. Yurdakul
Halil Yazici
Gulen Hatemi
Show All
Source
Cite
Save
Citations (0)
AB0542 REACTIONS TO PNEUMOCOCCAL 13-VALENT VACCINE IN PATIENTS WITH BEHCET SYNDROME
2020
Annals of the Rheumatic Diseases
Berna Yurttas
S. S. Taflan
N. Saltoglu
Gulen Hatemi
Show All
Source
Cite
Save
Citations (0)
1